<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Combination Actimid And Dexamethasone Regimen Is Promising For Relapsed And Refractory Myeloma Patients</title>
	<atom:link href="http://www.myelomabeacon.com/news/2009/09/04/combination-actimid-and-dexamethasone-regimen-is-promising-for-relapsed-and-refractory-myeloma-patients/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.myelomabeacon.com/news/2009/09/04/combination-actimid-and-dexamethasone-regimen-is-promising-for-relapsed-and-refractory-myeloma-patients/</link>
	<description>Multiple myeloma news, resources, and online forums for patients, caregivers, and others interested in multiple myeloma.</description>
	<lastBuildDate>Sat, 11 Feb 2012 16:18:32 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>By: Sidney Hider</title>
		<link>http://www.myelomabeacon.com/news/2009/09/04/combination-actimid-and-dexamethasone-regimen-is-promising-for-relapsed-and-refractory-myeloma-patients/comment-page-1/#comment-864</link>
		<dc:creator>Sidney Hider</dc:creator>
		<pubDate>Sun, 13 Sep 2009 23:15:35 +0000</pubDate>
		<guid isPermaLink="false">http://www.myelomabeacon.com/?p=8511#comment-864</guid>
		<description>This is another big step forward for myeloma treatment.
The issues of side effects are still there though seem somewhat reduced compared to Thalidomide, Velcade and Revlimide. Side effects still need to be addressed.
I await the future trials results with hope.
Sid.</description>
		<content:encoded><![CDATA[<p>This is another big step forward for myeloma treatment.<br />
The issues of side effects are still there though seem somewhat reduced compared to Thalidomide, Velcade and Revlimide. Side effects still need to be addressed.<br />
I await the future trials results with hope.<br />
Sid.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

